Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.12530/34627| Title: | Botulinum toxin type A in the treatment of Raynaud's phenomenon: A three-year follow-up study. | |
| Authors: | ||
| Issue Date: | Dec-2018 | |
| Citation: | Eur J Rheumatol.2018 Dec;(5)4:224-229 | |
| Abstract: | Raynaud's phenomenon consists of vasospastic disease of the digital arteries after exposure to cold or stress. It causes an important reduction in the patient's quality of life when severe. The available treatments do not always offer favorable results. | |
| PMID: | 30501848 | |
| URI: | https://hdl.handle.net/20.500.12530/34627 | |
| Rights: | openAccess | |
| ISSN: | 2147-9720 | |
| Appears in Collections: | Hospitales > H. U. Sureste > Artículos Fundaciones e Institutos de Investigación > FIB H. U. Príncipe de Asturias > Artículos | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| PMC6267752.pdf | 1.36 MB | Adobe PDF |  View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.